Table of Content

Chapter 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits to the Stakeholders
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
Chapter 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
Chapter 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Impacting Factors
3.2.2. Top Investment Pockets
3.3. Porter’s Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
Chapter 4: SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market Size and Forecast, By Product Type
4.2. Lancing Devices and Strips
4.3. Blood-Glucose Meter
Chapter 5: SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market Size and Forecast, By Application
5.2. Type-1 Diabetes
5.3. Type-2 Diabetes
Chapter 6: SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market Size and Forecast, By End User
6.2. Hospitals and Clinics
6.3. Home Care Settings
6.4. Others
Chapter 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2022
Chapter 8: COMPANY PROFILES
8.1. Abbott Laboratories
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Roche Diagnostics
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.2.7. Key strategic moves and developments
8.3. BD
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. Medtronic
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.4.7. Key strategic moves and developments
8.5. Siemens
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Nova Diabetes Care
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Bayer
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. Cansoft Technologies
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. Arkray
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. ACON Laboratories
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
8.10.7. Key strategic moves and developments



List of Figures

LIST OF FIGURES
FIGURE 01. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET (2023-2032)
FIGURE 04. PORTER FIVE-1
FIGURE 05. PORTER FIVE-2
FIGURE 06. PORTER FIVE-3
FIGURE 07. PORTER FIVE-4
FIGURE 08. PORTER FIVE-5
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 10. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET,BY PRODUCT TYPE, 2022 ($MILLION)
FIGURE 11. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET,BY APPLICATION, 2022 ($MILLION)
FIGURE 12. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET,BY END USER, 2022 ($MILLION)
FIGURE 13. TOP WINNING STRATEGIES, BY YEAR
FIGURE 14. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 15. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 16. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 17. COMPETITIVE DASHBOARD
FIGURE 18. COMPETITIVE HEATMAP: SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 19. TOP PLAYER POSITIONING, 2022
FIGURE 20. ABBOTT LABORATORIES: NET SALES, 2020-2022*?($MILLION)
FIGURE 21. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 22. ABBOTT LABORATORIES: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 23. ROCHE DIAGNOSTICS: NET SALES, 2020-2022*?($MILLION)
FIGURE 24. ROCHE DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 25. ROCHE DIAGNOSTICS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 26. BD: NET SALES, 2020-2022*?($MILLION)
FIGURE 27. BD: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 28. BD: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 29. MEDTRONIC: NET SALES, 2020-2022*?($MILLION)
FIGURE 30. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 31. MEDTRONIC: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 32. SIEMENS: NET SALES, 2020-2022*?($MILLION)
FIGURE 33. SIEMENS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 34. SIEMENS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 35. NOVA DIABETES CARE: NET SALES, 2020-2022*?($MILLION)
FIGURE 36. NOVA DIABETES CARE: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 37. NOVA DIABETES CARE: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 38. BAYER: NET SALES, 2020-2022*?($MILLION)
FIGURE 39. BAYER: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 40. BAYER: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 41. CANSOFT TECHNOLOGIES: NET SALES, 2020-2022*?($MILLION)
FIGURE 42. CANSOFT TECHNOLOGIES: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 43. CANSOFT TECHNOLOGIES: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 44. ARKRAY: NET SALES, 2020-2022*?($MILLION)
FIGURE 45. ARKRAY: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 46. ARKRAY: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 47. ACON LABORATORIES: NET SALES, 2020-2022*?($MILLION)
FIGURE 48. ACON LABORATORIES: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 49. ACON LABORATORIES: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

List of Tables

LIST OF TABLES
TABLE 01. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 02. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 03. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 04. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 05. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 06. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 07. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 08. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 09. ROCHE DIAGNOSTICS: KEY EXECUTIVES
TABLE 10. ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 11. ROCHE DIAGNOSTICS: OPERATING SEGMENTS
TABLE 12. ROCHE DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 13. ROCHE DIAGNOSTICS: KEY STRATERGIES
TABLE 14. BD: KEY EXECUTIVES
TABLE 15. BD: COMPANY SNAPSHOT
TABLE 16. BD: OPERATING SEGMENTS
TABLE 17. BD: PRODUCT PORTFOLIO
TABLE 18. BD: KEY STRATERGIES
TABLE 19. MEDTRONIC: KEY EXECUTIVES
TABLE 20. MEDTRONIC: COMPANY SNAPSHOT
TABLE 21. MEDTRONIC: OPERATING SEGMENTS
TABLE 22. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 23. MEDTRONIC: KEY STRATERGIES
TABLE 24. SIEMENS: KEY EXECUTIVES
TABLE 25. SIEMENS: COMPANY SNAPSHOT
TABLE 26. SIEMENS: OPERATING SEGMENTS
TABLE 27. SIEMENS: PRODUCT PORTFOLIO
TABLE 28. SIEMENS: KEY STRATERGIES
TABLE 29. NOVA DIABETES CARE: KEY EXECUTIVES
TABLE 30. NOVA DIABETES CARE: COMPANY SNAPSHOT
TABLE 31. NOVA DIABETES CARE: OPERATING SEGMENTS
TABLE 32. NOVA DIABETES CARE: PRODUCT PORTFOLIO
TABLE 33. NOVA DIABETES CARE: KEY STRATERGIES
TABLE 34. BAYER: KEY EXECUTIVES
TABLE 35. BAYER: COMPANY SNAPSHOT
TABLE 36. BAYER: OPERATING SEGMENTS
TABLE 37. BAYER: PRODUCT PORTFOLIO
TABLE 38. BAYER: KEY STRATERGIES
TABLE 39. CANSOFT TECHNOLOGIES: KEY EXECUTIVES
TABLE 40. CANSOFT TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 41. CANSOFT TECHNOLOGIES: OPERATING SEGMENTS
TABLE 42. CANSOFT TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 43. CANSOFT TECHNOLOGIES: KEY STRATERGIES
TABLE 44. ARKRAY: KEY EXECUTIVES
TABLE 45. ARKRAY: COMPANY SNAPSHOT
TABLE 46. ARKRAY: OPERATING SEGMENTS
TABLE 47. ARKRAY: PRODUCT PORTFOLIO
TABLE 48. ARKRAY: KEY STRATERGIES
TABLE 49. ACON LABORATORIES: KEY EXECUTIVES
TABLE 50. ACON LABORATORIES: COMPANY SNAPSHOT
TABLE 51. ACON LABORATORIES: OPERATING SEGMENTS
TABLE 52. ACON LABORATORIES: PRODUCT PORTFOLIO
TABLE 53. ACON LABORATORIES: KEY STRATERGIES